175 related articles for article (PubMed ID: 6563941)
1. Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.
de Jong WH; Steerenberg PA; Kreeftenberg JG; Tiesjema RH; Kruizinga W; van Noorle Jansen LM; Ruitenberg EJ
Cancer Immunol Immunother; 1984; 17(1):18-27. PubMed ID: 6563941
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-Guérin.
Steerenberg PA; De Jong WH; Geerse E; Aleva BJ; Besselink CM; Van Rens BT; Rutten VP; Poels LG; Scheper RJ; Den Otter W
Cancer Immunol Immunother; 1990; 32(2):95-104. PubMed ID: 1963114
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex class II antigen expression on leucocyte subpopulations in the draining lymph node and tumour in the early phase of bacillus-Calmette-Guérin-induced tumour regression.
Steerenberg PA; De Jong WH; Geerse E; De Graaf A; Scheper RJ; Den Otter W; Ruitenberg EJ
Cancer Immunol Immunother; 1991; 33(3):189-97. PubMed ID: 1828389
[TBL] [Abstract][Full Text] [Related]
4. Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pig.
van der Meijden AP; de Jong WH; de Boer EC; Steerenberg PA; Debruyne FM; Ruitenberg EJ
Urol Res; 1989; 17(1):47-55. PubMed ID: 2922891
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.
Rutten VP; Klein WR; De Jong WA; Misdorp W; Steerenberg PA; De Jong WH; Den Otter W; Ruitenberg EJ
Cancer Immunol Immunother; 1991; 34(3):186-90. PubMed ID: 1756535
[TBL] [Abstract][Full Text] [Related]
6. Role of Th1-stimulating cytokines in bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells.
Luo Y; Yamada H; Evanoff DP; Chen X
Clin Exp Immunol; 2006 Oct; 146(1):181-8. PubMed ID: 16968412
[TBL] [Abstract][Full Text] [Related]
7. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Fidler IJ; Kataoka T; Hanna MG
Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
[TBL] [Abstract][Full Text] [Related]
8. Variation of growth in the production of the BCG vaccine and the association with the immune response. An observational study within a randomised trial.
Biering-Sørensen S; Jensen KJ; Aamand SH; Blok B; Andersen A; Monteiro I; Netea MG; Aaby P; Benn CS; Hasløv KR
Vaccine; 2015 Apr; 33(17):2056-65. PubMed ID: 25765965
[TBL] [Abstract][Full Text] [Related]
9. Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin.
van der Meijden AP; Steerenberg PA; van Hoogstraaten IM; Kerckhaert JA; Schreinemachers LM; Harthoorn-Lasthuizen EJ; Hagenaars AM; de Jong WH; Debruijne FM; Ruitenberg EJ
Cancer Immunol Immunother; 1989; 28(4):287-95. PubMed ID: 2784716
[TBL] [Abstract][Full Text] [Related]
10. Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection.
Kato K; Yamamoto K
Immunology; 1982 Apr; 45(4):655-61. PubMed ID: 6175566
[TBL] [Abstract][Full Text] [Related]
11. Enhancing effect of an inhibitor of nitric oxide synthesis on bacillus Calmette-Guerin-induced macrophage cytotoxicity against murine bladder cancer cell line MBT-2 in vitro.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
Jpn J Cancer Res; 2000 May; 91(5):534-42. PubMed ID: 10835499
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
13. Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer.
Bennett JA; Gruft H; McKneally MF; Zelterman D; Crispen RG
Cancer Res; 1983 Sep; 43(9):4183-90. PubMed ID: 6347367
[TBL] [Abstract][Full Text] [Related]
14. Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages.
van Dissel JT; Stikkelbroeck JJ; van den Barselaar MT; Sluiter W; Leijh PC; van Furth R
J Immunol; 1987 Sep; 139(5):1665-72. PubMed ID: 2957432
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.
Klein WR; Ruitenberg EJ; Steerenberg PA; de Jong WH; Kruizinga W; Misdorp W; Bier J; Tiesjema RH; Kreeftenberg JG; Teppema JS; Rapp HJ
J Natl Cancer Inst; 1982 Nov; 69(5):1095-103. PubMed ID: 6957655
[TBL] [Abstract][Full Text] [Related]
16. Histological evaluation of immunologically mediated tumor regression of the line 10 guinea pig hepatocarcinoma.
de Jong WH; Teppema JS; Wagenaar SS; Paques M; Steerenberg PA; Ruitenberg EJ
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 50(3):249-69. PubMed ID: 2870577
[TBL] [Abstract][Full Text] [Related]
17. Bacillus Calmette-Guérin (BCG) decreases resistance to Listeria monocytogenes infection in mice.
Wing EJ
Immunology; 1981 Nov; 44(3):509-15. PubMed ID: 7319550
[TBL] [Abstract][Full Text] [Related]
18. BCG immunopotentiation of an antitumor response: evidence for a cell-mediated mechanism.
Hawrylko E
J Natl Cancer Inst; 1975 Aug; 55(2):413-23. PubMed ID: 808641
[TBL] [Abstract][Full Text] [Related]
19. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
de Jong WH; van de Plas MM; Steerenberg PA; Kruizinga W; Ruitenberg EJ
J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526
[TBL] [Abstract][Full Text] [Related]
20. Effects of sequential intravesical administration of mitomycin C and bacillus Calmette-Guérin on the immune response in the guinea pig bladder.
Balemans LT; Vegt PD; Steerenberg PA; De Boer EC; Van Swaaij A; De Vries RE; Van der Meijden AP; Den Otter W
Urol Res; 1994; 22(4):239-45. PubMed ID: 7871637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
